Quick Answer
LIPELLA PHARMACEUTICALS INC. reported Shares Outstanding of 1.21 million shares for fiscal year 2024.
LIPELLA PHARMACEUTICALS INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 1.21M | +59.8% |
| 2023 | 756,743 | -86.8% |
| 2022 | 5.74M | +48.6% |
| 2021 | 3.87M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 4.62M | +323.5% | +3.4% |
| June 30, 2025 | 4.47M | -41.3% | +75.3% |
| March 31, 2025 | 2.55M | -63.8% | +110.8% |
| December 31, 2024 | 1.21M | +59.8% | +10.8% |
| September 30, 2024 | 1.09M | -81.2% | -85.7% |
| June 30, 2024 | 7.61M | +32.4% | +8.0% |
| March 31, 2024 | 7.04M | +22.6% | +830.3% |
| December 31, 2023 | 756,745 | -86.8% | -87.0% |
- LIPELLA PHARMACEUTICALS INC. showed an increase of +59.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2024 period, LIPELLA PHARMACEUTICALS INC.’s shares outstanding has declined by 68.7% (from 3.87 million shares to 1.21 million shares).
- The most recent figure is from LIPELLA PHARMACEUTICALS INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: